Ecstasy as Cancer Drug?
The illegal club drug Ecstasy can trigger euphoria among the dance club set, but can it ease the debilitating anxiety that cancer patients feel as they face their final days? The Food and Drug Administration has approved a pilot study looking at whether the recreational hallucinogen can help terminally ill patients lessen their fears, quell thoughts of suicide and make it easier for them to deal with loved ones. “End of life issues are very important and are getting more and more attention, and yet there are very few options for patients who are facing death,” Dr. John Halpern, the Harvard research psychiatrist in charge of the study, said Monday.
The small, four-month study is expected to begin early next spring. It will test the drug’s effects on 12 cancer patients from the Lahey Clinic Medical Center in the Boston area. The research is being sponsored by the Multidisciplinary Association for Psychedelic Studies, a nonprofit group that plans to raise $250,000 to fund it.
MAPS, on its web site, touted the study’s approval, saying “the longest day of winter has passed, and maybe so has the decades-long era of resistance to psychedelic research.”
The FDA would not comment, but this will be the second FDA-approved study using Ecstasy this year. South Carolina researchers are studying the effects of Ecstasy on 20 patients suffering from post traumatic stress disorder.
Interesting. It would be ironic indeed, though, for the FDA to approve medical use of Ecstasy, a much more potent drug, while continuing to resist the use of marijuana for similar purposes.